Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Peroxide or compositions of or releasing gaseous oxygen or...
Reexamination Certificate
2006-11-21
2006-11-21
Lankford, Leon (Department: 1651)
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Peroxide or compositions of or releasing gaseous oxygen or...
C514S251000, C514S276000, C514S356000, C514S474000
Reexamination Certificate
active
07138146
ABSTRACT:
The subject of the present invention is acrochordon removal and prevention utilizing safe dependable effective biocompatable treatments with no scarring, bleeding, twisting, yanking, choking, burning, freezing, shocking, screaming and hypo pigmentation or hyper pigmentation. In one aspect of the invention, methods are provided for acrochordon removal comprising application of high concentrations of hydrogen peroxide.
REFERENCES:
patent: 3954974 (1976-05-01), Herzog et al.
patent: 4018802 (1977-04-01), Cragoe et al.
patent: 4128564 (1978-12-01), Cragoe et al.
patent: 4438102 (1984-03-01), Ganci
patent: 4485091 (1984-11-01), Fitton
patent: 4826681 (1989-05-01), Jacquet et al.
patent: 5362915 (1994-11-01), Maschler et al.
patent: 5380764 (1995-01-01), Herzog
patent: 5472715 (1995-12-01), Uehara
patent: 5594015 (1997-01-01), Kurtz et al.
patent: 5736582 (1998-04-01), Devillez
patent: 5824694 (1998-10-01), Kurtz et al.
patent: 5958984 (1999-09-01), Devillez
patent: 6028104 (2000-02-01), Schmidt et al.
patent: 6146640 (2000-11-01), Kyke
patent: 2285218 (1995-07-01), None
Beitler et al., “Association between acrochordons and colonic polyps,”J. Am. Acad. Dermatol.,14:1042-1044, 1986.
Bilotta and Waye, “Hydrogen Peroxide Enteritis: the “Snow White” Sign,”Gastrointestinal Endoscopy,35: 428-430; 1989.
Christensen et al., “Fatal Oxygen Embolization after Hydrogen Peroxide Ingestion,”Critical Care Medicine,20(4): 543-544; 1992.
Cornell and Stoughton, “Correlation of the vasoconstriction assay and clinical activity in Psoriasis,”Arch Dermatol.,121:63-67, 1985.
Danis Brodeur, “The Danger of Hydrogen Peroxide as a Colonic Irrigating Solution,”Journal of Pediatric Surgery,2(2): 131-133; 1967.
Dickson et al., “Hydrogen peroxide exposure—325 exposures reported to a regional poison control center,”Clinical Toxicology,32(6):705-714, 1994.
Ellis et al., “Increased epidermal growth factor receptors in seborrheic keratoses and acrochordons of patients with the dysplastic nevus syndrome,”J. Am. Acad. Dermatol,23:1070-1077, 1990.
Giberson et al., “Near-fatal hydrogen peroxide ingestion,”Annals of Emergency Medicine,18:119-120/778-779, 1989.
Goette et al., “Skin Blanching Induced by Hydrogen Peroxide,”Southern Medical Journal,70(5): 620-622; 1977.
Goette, “Hydrogen peroxide-induced skin blanching,”Arch Dermatol,112:1788-1789, 1976.
Gruber et al., “The effect of commonly used antiseptics on wound healing,”Antiseptics and Wound Healing,55(4):472-476, 1975.
Henry et al., “Hydrogen Peroxide 3% Exposures,”Clinical Toxicology,34(3): 323-327; 1996.
Hocutt, “Skin cryosurgery for the family physician,”American Family Physicians,48:445-452, 1993.
Humberston et al., “Ingestion of 35% Hydrogen Peroxide,”Clinical Toxicology,28(1):95-100; 1990.
Klein-Szanto and Slaga, “Effects of Peroxides on Rodent Skin: Epidermal Hyperplasia and Tumor Promotion,”The Journal of Investigative Dermatology,79: 30-34; 1982.
Leavitt et al., “Skin tags: a cutaneous marker for colonic polyps,”Annals of Internal Med.,98:928-930, 1983.
Nanney et al., “Altered distribution of phospholipase C-γ1 in Benign hyperproliferative epidermal diseases,”Cell Growth&Differentiation,3:233-239, 1992.
Nanney et al., “Epidermal growth factor receptors in idiopathic and virally induced skin diseases,”Am. J. Pathology,140(4):915.
O'Toole et al., “Hydrogen Peroxide Inhibits Human Keratinocyte Migration,”Dermatologic Surgery,22: 525-529; 1996.
Oliver and Murphy, “Influenzal Pneumonia: the intavenous injection of hydrogen peroxide,”The Lancet,432-433, 1920.
Pumphrey, “Hydrogen peroxide procitits,”American J. of Surgery,81:60-62, 1951.
Rathbun, “A Method for Removing the Acrochordon (Skin Tag),”Kansas Medicine,91(1): 11-12; 1990.
Sebben, “The hazards of electrosurgery,”J. Am. Acad. Dermatol.,16(4):869-872, 1987.
Segal, “Liquid nitrogen therapy,”Australian Family Physician,13:356-357, 1984.
Strohmer et al., “Use of hydrogen peroxide for vaginal contraception,”Human Reproduction,12:1599, 1997.
Strother, “Acrochordonectomy made easy,”Clinician Reviews,8(3):154-155, 1998.
Tegner and Björnberg, “Hydrogen Peroxide Cream for the Prevention of White Pressure Areas in UVA Sunbeds,”Acta Dermatologica Venereologica(Stockholm), 70: 75-76; 1990.
Tegner, “Induction of Skin Blanching by Hydrogen Peroxide,”Acta Dermatologica Venereologica(Stockholm), 74: 474-475; 1994.
Tur et al., “Topical hydrogen peroxide treatment of ischemic ulcers in the guinea pig: blood recruitment in multiple skin sites,”Journal of the American Academy of Dermatology,33: 217-221; 1995.
“Seborrheic and Senile Keratoses” by M.R. Caro, et al.,Medical Clinics of North America,vol. 35, pp. 419-431.
“Differenting Seborrheic Keratosis from Skin Neoplasm” by R.W. Cashmore, et al.,Geniatrics,vol. 40, pp. 69-75 (1985).
“Curetting for Seborrheic Keratose” by J.L. Eberlin,Plastic and Reconstructive Surgery,vol. 101, No. 2, pp. 546-547 (1998).
“Malignant Melanoma Appearing in a Seborrhoeic Keratosis” by M. Jones-Caballero, et al.,British Journal of Dermatology,vol. 133, pp. 1016-1018 (1995).
“Cellular Response of Seborrheic Keratosis Following Croton Oil Irritation and Surgical Trauma with Special Reference to Melanoacanthoma” by B. Mevorah, et al.,Dermatologica,vol. 131, pp. 452-464 (1965).
“Seborrhoeic Keratoses: Scarless Removal by Curettage and Oxidized Cellulose” by F.E. Mohs,Journal of the American Medical Association,vol. 212, No. 11, pp. 1956-1958 (1970).
“The Management of Seborrhoeic Keratoses by General Practitioners, Surgeons, and Dermatologists” by J.M. Sowden, et al.,British Journal of Dermatology,vol. 139, pp. 348-349 (1998).
“Cryosurgery for Common Skin Lesions: Treatment in Family Physicians'Offices” by S.J. Wetmore,Cutis,vol. 63, pp. 235-237 (1999).
“Malignant Melanoma Appearing in Seborrheic Keratosis” by J.B. Yakar, et al.,Journal of Dermatologic Surgery and Oncology,vol. 10, pp. 382-383 (1994).
Lee and Choi, “TCA chemical peeling. Procedures, complication and self-evaluation of therapeutic effect in 242 patients,”Korean Journal of Dermatology,31:1-8, 1993, (ABSTRACT).
CV2003-020242, Physicians Choice of Arizona, Inc. vs. Mickey Miller et al., Mickey Miller's Answer and Counter Claim, filed Dec. 2, 2003.
Ancira Margaret
Miller Mickey
Hecker LLP Stinson Morrison
Lankford Leon
Rosenbaum & Associates, PC
LandOfFree
Acrochordon alleviation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acrochordon alleviation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acrochordon alleviation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3672576